Pairwise Meta-Analysis for Chemotherapy Cohorts ( Supplementary Results 9 ) The use of PPIs is associated with a significant 12% higher all-cause mortality in patients with advanced NSCLC receiving chemotherapy, with a marginally significant higher progression rate ( Supplementary Figures S35 and S36 ).
← all excerpts
The Association between Baseline Proton Pump Inhibitors, Immune Checkpoint Inhibitors, and Chemotherapy: A Systematic Review with Network Meta-Analysis.
1
—
—